Editorial: monitoring blood pressure is key to the safe use of beta-blockers in patients with chronic liver failure

Aliment Pharmacol Ther. 2018 Jan;47(2):300-301. doi: 10.1111/apt.14402.

Authors

J W Ferguson^{1

2}, M J Armstrong^{1

2}

Affiliations

¹ Institute of Immunology and Immunotherapy, National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK.
² Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Birmingham, UK.

PMID: 29265458
DOI: 10.1111/apt.14402

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adrenergic beta-Antagonists
Ascites
Blood Pressure*
End Stage Liver Disease*
Humans
Liver Cirrhosis

Substances

Adrenergic beta-Antagonists